NCT07608913 Effect of Hot Spring Therapy on Cognitive Function Recovery During Altitude Training
| NCT ID | NCT07608913 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Macao Polytechnic University |
| Condition | Altitude Training Adaptation |
| Study Type | INTERVENTIONAL |
| Enrollment | 27 participants |
| Start Date | 2026-05-25 |
| Primary Completion | 2026-06-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 27 participants in total. It began in 2026-05-25 with a primary completion date of 2026-06-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to investigate the effects of hot spring bath therapy on cognitive function recovery, cerebral hemodynamics, and athletic performance in athletes undergoing altitude training. Participants will be randomly assigned to either a hot spring intervention group, a hot water control group, or a blank control group. The hot spring intervention group receives hot spring baths (38°C, 20 minutes) combined with altitude training; the hot water control group receives hot water baths (38°C, 20 minutes) combined with altitude training; and the blank control group receives standard recovery procedures combined with altitude training. Primary outcome measures include cognitive performance assessments (Stroop test, psychomotor vigilance test) and cerebral hemodynamic indicators (functional near-infrared spectroscopy, transcranial Doppler ultrasound). Secondary outcomes included exercise capacity (maximal oxygen uptake, triathlon performance, 500-meter test), blood lactate, and hematological parameters (white blood cells, neutrophils, platelets). These findings may provide evidence for non-pharmacological interventions to enhance cognitive recovery and brain adaptation during altitude training.
Eligibility Criteria
Inclusion Criteria: * Male or female aged 11-17 years- Regular endurance training (≥3 sessions/week) for ≥2 years * No history of altitude exposure \>2000m in the past 3 months * No contraindications to hot water immersion (e.g., uncontrolled hypertension, severe cardiovascular disease, open wounds, pregnancy) * Ability to provide written informed consent * Willingness to abstain from other recovery modalities (e.g., massage, cryotherapy, compression garments) during the study period * No color blindness or uncorrected visual impairment that would affect Stroop test performance Exclusion Criteria: * History of cardiovascular, respiratory, renal, or endocrine disorders * Current use of medications affecting autonomic function or cognition (e.g., beta-blockers, anticholinergics, stimulants, sedatives) * History of syncope, heat intolerance, or neurological disorders * Acute musculoskeletal injury within the past 6 months- Regular use of sauna, hot tub, or spa within the past month- Pregnancy or breastfeeding (for female participants) * Shift work or trans-meridian travel within 2 weeks prior to baseline assessment- Alcohol consumption \>14 units/week or smoking * History of traumatic brain injury, stroke, or psychiatric disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07608913 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Altitude Training Adaptation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07608913 currently recruiting?
Yes, NCT07608913 is actively recruiting participants. Contact the research team at 395356506@qq.com for enrollment information.
Where is the NCT07608913 trial being conducted?
This trial is being conducted at Macao, China.
Who is sponsoring the NCT07608913 clinical trial?
NCT07608913 is sponsored by Macao Polytechnic University. The trial plans to enroll 27 participants.